| CONTACT: |
| Supreme Court of the Philippines Library Services, Padre Faura, Ermita, Manila, Philippines 1000 |
| (632) 8524-2706 |
| libraryservices.sc@judiciary.gov.ph |
(NAR) VOL. 15 NOS. 1-2 / JANUARY - MARCH 2004
[ DOH ADMINISTRATIVE ORDER NO. 107, S. 2003, October 27, 2003 ]
GUIDELINES ON THE IMPLEMENTATION OF THE DRUG TEST OPERATIONS MANAGEMENT SYSTEM (DTOMIS)
I. BACKGROUND/RATIONALE
The task of regulating Drug Test Laboratories/Centers (DTL/DTC) is a function of the Department of Health in accordance with the provisions of Republic Act No. 9165 also known as "Comprehensive Dangerous Drugs Act of 2002".
Article III, "Dangerous Drug Test and Record Requirement" of the said law in particular has specifically mandated the DOH to license, accredit, and monitor Drug Test Laboratories/Centers to ensure quality of drug testing results; accredit physicians for drug dependency examination and provision of care; and establish, operate and maintain DTL/DTCs in government hospitals.
Section 6, No. 5 of the DOH Implementing Rules and Regulations governing the licensing and accreditation of DTLs/DTCs requires that the DOH to approve the Application Service Provider for effective authentication of test results and prompt interface with Information and Communication Technology (ICT) systems of Agency Data Beneficiaries of drug test results.
On August 27, 2003, the Congressional Oversight Committee on Dangerous Drugs instructed the DOH to set up a "stop gap" ICT solution within one month that will supplant the current operation of an ASP operating within the administrative and regulation framework of the Land Transportation Office. As a consequence of said instruction the DOH developed the Drug Test Operations Management System (DTOMIS) software, enhanced the current available ICT infrastructure of the DOH, and trained DOH personnel strategically distributed throughout the country. The implementation of DTOMIS is a paramount thrust to reduce the cost of drug testing.
And as approved by the Dangerous Drugs Board (DDB) in its October 24, 2003 meeting the DTOMIS is hereby adopted for implementation and until such time appropriate enhancements are introduced as determined by the DOH and concurred by the DDB.
II. OBJECTIVES
The Drug Test Operation Management Information System has the following objectives:
III. SCOPE AND COVERAGE
This Order shall cover all Drug Test Laboratories/Centers, the Department of Health, including its Centers for Health Development (CHD) and Retained Hospitals, and the Agency Data Beneficiaries.
IV. GENERAL GUIDELINES
V. AGENCY DATA BENEFICIARIES
The Agency Data Beneficiaries are the Government Agencies, which are members of the Dangerous Drugs Board and other entities, as may be determined by the Department of Health and the Dangerous Drugs Board.
VI. IMPLEMENTING ANNEXES
The implementing annexes of this Order can be found at the DOH website for DTOMIS (http://dtomis.gov.ph) and are listed as follows:
VII. REPEALING CLAUSE
Provisions of previous issuance, which are contrary or inconsistent with those provided in this Order are hereby rescinded or modified accordingly.
VIII. SEPARABILITY CLAUSE
If any provision in these Guidelines, or application of such provision to any circumstance, is held invalid, the remainder of these Guidelines shall not be affected thereby.
IX. EFFECTIVITY
This Order shall be effective immediately.
Adopted: 27 Oct. 2003
(SGD.) MANUEL M. DAYRIT, MD, MSc
Secretary of Health
The task of regulating Drug Test Laboratories/Centers (DTL/DTC) is a function of the Department of Health in accordance with the provisions of Republic Act No. 9165 also known as "Comprehensive Dangerous Drugs Act of 2002".
Article III, "Dangerous Drug Test and Record Requirement" of the said law in particular has specifically mandated the DOH to license, accredit, and monitor Drug Test Laboratories/Centers to ensure quality of drug testing results; accredit physicians for drug dependency examination and provision of care; and establish, operate and maintain DTL/DTCs in government hospitals.
Section 6, No. 5 of the DOH Implementing Rules and Regulations governing the licensing and accreditation of DTLs/DTCs requires that the DOH to approve the Application Service Provider for effective authentication of test results and prompt interface with Information and Communication Technology (ICT) systems of Agency Data Beneficiaries of drug test results.
On August 27, 2003, the Congressional Oversight Committee on Dangerous Drugs instructed the DOH to set up a "stop gap" ICT solution within one month that will supplant the current operation of an ASP operating within the administrative and regulation framework of the Land Transportation Office. As a consequence of said instruction the DOH developed the Drug Test Operations Management System (DTOMIS) software, enhanced the current available ICT infrastructure of the DOH, and trained DOH personnel strategically distributed throughout the country. The implementation of DTOMIS is a paramount thrust to reduce the cost of drug testing.
And as approved by the Dangerous Drugs Board (DDB) in its October 24, 2003 meeting the DTOMIS is hereby adopted for implementation and until such time appropriate enhancements are introduced as determined by the DOH and concurred by the DDB.
II. OBJECTIVES
The Drug Test Operation Management Information System has the following objectives:
- To provide interconnectivity and standardized solution for accredited DTLs/DTCs so that the results may be used by other Agencies;
- To provide an efficient and effective system for updating, maintaining, sharing and accessing voluminous transaction data that are repeated annually;
- To enforce standards on input, process, and output to simplify registration and results verification and monitoring;
- To produce accurate, reliable and timely drug testing data;
- To improve client satisfaction through better, faster, more convenient and cheaper public service;
- To strengthen DTL/DTC quality assurance program;
- To generate at least PhP 1 billion annual savings from the aggregate expenses of persons required to be drug tested.
III. SCOPE AND COVERAGE
This Order shall cover all Drug Test Laboratories/Centers, the Department of Health, including its Centers for Health Development (CHD) and Retained Hospitals, and the Agency Data Beneficiaries.
IV. GENERAL GUIDELINES
- Effective 03 October 2003, the Information Management Service must assure that the DTOMIS software is deployed to all DOH trained personnel assigned at the CHDs;
- Effective 03 October 2003, the DOH and its CHDs shall deploy the DTOMIS software to all DOH accredited DTLs/DTCs. Deployment of the software to the DTLs/DTCs includes installation, provision of minimum training and doctrine materials, and registration of Drug Test Kits. The Drug Test Results generated from the DTOMIS shall be deemed officially acceptable reckoned from this date;
- Effective November 3, 2003, only drug test results generated by the DTOMIS shall be accepted as Official by the DOH and all the Agency Data Beneficiaries. Accredited DTCs/DTLs including newly accredited ones, however, must contact the CHD under which they are regulated or the DOH Central Office for the installation of the DTOMIS software and registration of drug kits onwards the subject date as a continuing process;
- The DOH shall transfer the Security Codes for authenticating the Drug Test Results to the Head of the Agency Data Beneficiary as shall be explicitly requested by the latter. The Agency Data Beneficiary shall exert due diligence in protecting the confidentiality of the said codes and the persons under it that are authorized to have direct knowledge of the said codes. The Agency Data Beneficiary shall explicitly identify the personnel who are authorized to have direct knowledge of the said codes and must be sworn to protect their confidentiality and must be made aware of the implications and sanctions that may be imposed as a result of infidelity to hold state secret.
- The Bureau of Health Facilities and Services, in coordination with the Information Management Service shall harmonize regulatory standards and processes with the Information and Communication Technology Intervention and other future enhancements as may be deemed appropriate.
V. AGENCY DATA BENEFICIARIES
The Agency Data Beneficiaries are the Government Agencies, which are members of the Dangerous Drugs Board and other entities, as may be determined by the Department of Health and the Dangerous Drugs Board.
VI. IMPLEMENTING ANNEXES
The implementing annexes of this Order can be found at the DOH website for DTOMIS (http://dtomis.gov.ph) and are listed as follows:
Annex A - DTOMIS Manual
Annex B - Implementing Procedure for the Centers for Health Development
Annex C - Implementing Procedure for the Drug Test Centers
Annex D - Implementing Procedure for the Information Management Service
Annex E - Terms and Condition for DTOMIS Software Use
Annex F - Drug test Kit Registration Procedure
VII. REPEALING CLAUSE
Provisions of previous issuance, which are contrary or inconsistent with those provided in this Order are hereby rescinded or modified accordingly.
VIII. SEPARABILITY CLAUSE
If any provision in these Guidelines, or application of such provision to any circumstance, is held invalid, the remainder of these Guidelines shall not be affected thereby.
IX. EFFECTIVITY
This Order shall be effective immediately.
Adopted: 27 Oct. 2003
Secretary of Health